Related Experiment Videos
Ligand-independent antiapoptotic function of estrogen receptor-beta in lung cancer cells
Guangfeng Zhang1, Naveena Yanamala, Kira L Lathrop
1Division of Endocrinology and Metabolism, University of Pittsburgh, E1115 Starzl Biomedical Science Tower, 200 Lothrop Street, Pittsburgh, PA 15261, USA.
Abstract:
Recent studies have demonstrated the presence of estrogen receptor (ER)beta in the mitochondria in various cell types and tissues, but the exact function of this localization remains unclear. In this study, we have examined the function of mitochondrial ERbeta in non-small-cell lung cancer (NSCLC) cells. Down-regulation of ERbeta by short hairpin RNA constructs sensitized NSCLC cells to various apoptosis-inducing agents such as cisplatin, taxol, and etoposide. The increased growth inhibition and induction of apoptosis in ERbeta-knockdown cells was observed irrespective of estrogen treatment, suggesting a ligand-independent role of ERbeta in regulating the intrinsic apoptotic pathway. Further, ERbeta from the mitochondrial fraction physically interacted with the proapoptotic protein Bad, in a ligand-independent manner. Glutathione-S-transferase pull-down assays and molecular modeling studies revealed that the DNA-binding domain and hinge region of ERbeta, and the BH3 domain of Bad were involved in these interactions. Further investigations revealed that ERbeta inhibited Bad function by disrupting Bad-Bcl-X(L) and Bad-Bcl-2 interactions. Reintroduction of ERbeta in the mitochondria of ERbeta knockdown cells reversed their sensitivity to cisplatin. Overall, our results demonstrate a ligand-independent role of ERbeta in regulating apoptosis, revealing a novel function for ERbeta in the mitochondria.
Insights
Mitochondrial estrogen receptor beta (ERbeta) plays a key role in non-small-cell lung cancer apoptosis. This ERbeta form regulates apoptosis independently of estrogen, interacting with the Bad protein to control cell death.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Estrogen receptor (ER)beta has been identified in mitochondria, but its function there is largely unknown.
- Mitochondrial ERbeta's role in cancer, particularly non-small-cell lung cancer (NSCLC), requires further investigation.
Purpose of the Study:
- To elucidate the function of mitochondrial ERbeta in non-small-cell lung cancer (NSCLC) cells.
- To determine if ERbeta's role in apoptosis is ligand-dependent or independent.
Main Methods:
- Short hairpin RNA (shRNA) was used to down-regulate ERbeta in NSCLC cells.
- Apoptosis-inducing agents (cisplatin, taxol, etoposide) were used to assess cell sensitivity.
- Glutathione-S-transferase (GST) pull-down assays and molecular modeling were employed to study protein interactions.
- Reintroduction of ERbeta into knockdown cells was performed to confirm findings.
Main Results:
- ERbeta knockdown sensitized NSCLC cells to apoptosis-inducing agents, irrespective of estrogen.
- Mitochondrial ERbeta physically interacted with the proapoptotic protein Bad in a ligand-independent manner.
- ERbeta inhibited Bad function by disrupting its interactions with Bcl-xL and Bcl-2, thereby regulating apoptosis.
Conclusions:
- Mitochondrial ERbeta plays a significant role in regulating apoptosis in NSCLC cells.
- This function is ligand-independent, highlighting a novel role for ERbeta beyond its nuclear functions.
- ERbeta's interaction with Bad offers a new therapeutic target for NSCLC treatment.
Related Concept Videos
Mitogens and the Cell Cycle
The Intrinsic Apoptotic Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The Extrinsic Apoptotic Pathway
Regulation of Angiogenesis and Blood Supply
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...